Trials / Conditions / Rituximab (RTx)
Rituximab (RTx)
4 registered clinical trials studyying Rituximab (RTx) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With R NCT06906549 | University Hospital, Strasbourg, France | Phase 4 |
| Active Not Recruiting | A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospect NCT06949241 | Ruijin Hospital | — |
| Completed | Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients NCT07457944 | Ruijin Hospital | — |
| Completed | Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transpl NCT01136395 | University of Giessen | Phase 2 |